BioAge
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5885 Hollis St Ste 370, Emeryville, Cali...Phone Number
(510) 806-1445Website
www.bioagelabs.comRevenue
$10.4 MillionStock Symbol
BIOAIndustry
About BioAge
BioAge is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Our proprietary platform, which encompasses 65M molecular measurements spanning 45+ years of human aging, unlocks a universe of novel biological insights and druggable mechanisms for age-related disease. The companys lead program, azelaprag, is a potential first-in-class oral APJ agonist entering Phase 2 trials in combination with tirzepatide for the treatment of obesity in older adults. Azelaprag has the potential as an oral regimen to amplify weight loss and improve body composition in patients on obesity therapy with incretin drugs. BioAges preclinical programs address key pathways in metabolic aging, based on novel insights from its discovery platform built on human longevity data.Explore more
SIC Code 87,873NAICS Code 54,541Ticker NASDAQ: BIOAShow moreBioAge Org Chart
Compare Similar Companies to BioAge
Compare insights from companies similar to BioAge, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$132.7M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
BioAge Tech Stack
A closer look at the technologies used by BioAge
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioAge
Sign Up For FreeTo access detailed company insights
BioAge is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Our proprietary platform, which encompasses 65M molecular measurements spanning 45+ years of human aging, unlocks a universe of novel biological insights and druggable mechanisms for age-relat... Read More